Matt Wade
Matt supports the Biopharma Journal Finance editorial team with reporting, research, and audience development. He was previously with WallStreet International in NYC.
Recent Post
Kodiak Sciences Inc (KOD): A Promising Bet in the Biopharmaceutical Space...
In the bustling arena of biopharmaceutical advancements, Kodiak Sciences Inc. (NASDAQ:KOD) is emerging as a key player, particularly in the field of...
